There is, I think, something ethereal about i —the square root of minus one. I remember first hearing about it at school. It seemed an odd beast at that time—an intruder hovering on the edge of reality.

Usually familiarity dulls this sense of the bizarre, but in the case of i it was the reverse: over the years the sense of its surreal nature intensified. It seemed that it was impossible to write mathematics that described the real world in …

I and i

Lipid peroxidation can be described generally as a process under which oxidants such as free radicals attack lipids containing carbon-carbon double bond(s), especially polyunsaturated fatty acids (PUFAs). Over the last four decades, an extensive body of literature regarding lipid peroxidation has shown its important role in cell biology and human health. Since the early 1970s, the total published research articles on the topic of lipid peroxidation was 98 (1970–1974) and has been increasing at almost 135-fold, by up to 13165 in last 4 years (2010–2013). New discoveries about the involvement in cellular physiology and pathology, as well as the control of lipid peroxidation, continue to emerge every day. Given the enormity of this field, this review focuses on biochemical concepts of lipid peroxidation, production, metabolism, and signaling mechanisms of two main omega-6 fatty acids lipid peroxidation products: malondialdehyde (MDA) and, in particular, 4-hydroxy-2-nonenal (4-HNE), summarizing not only its physiological and protective function as signaling molecule stimulating gene expression and cell survival, but also its cytotoxic role inhibiting gene expression and promoting cell death. Finally, overviews of in vivo mammalian model systems used to study the lipid peroxidation process, and common pathological processes linked to MDA and 4-HNE are shown.

/pdf/lipid-peroxidation-production-metabolism-and-signaling-234bwmyps5.pdf

Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal.

Free radicals and oxidants play a dual role as both toxic and beneficial compounds, since they can be either harmful or helpful to the body. They are produced either from normal cell metabolisms in situ or from external sources (pollution, cigarette smoke, radiation, medication). When an overload of free radicals cannot gradually be destroyed, their accumulation in the body generates a phenomenon called oxidative stress. This process plays a major part in the development of chronic and degenerative illness such as cancer, autoimmune disorders, aging, cataract, rheumatoid arthritis, cardiovascular and neurodegenerative diseases. The human body has several mechanisms to counteract oxidative stress by producing antioxidants, which are either naturally produced in situ, or externally supplied through foods and/or supplements. This mini-review deals with the taxonomy, the mechanisms of formation and catabolism of the free radicals, it examines their beneficial and deleterious effects on cellular activities, it highlights the potential role of the antioxidants in preventing and repairing damages caused by oxidative stress, and it discusses the antioxidant supplementation in health maintenance.

/pdf/free-radicals-antioxidants-in-disease-and-health-4hj2vo5so4.pdf

Free Radicals, Antioxidants in Disease and Health

Melatonin is a highly conserved molecule. Its presence can be traced back to ancient photosynthetic prokaryotes. A primitive and primary function of melatonin is that it acts as a receptor-independent free radical scavenger and a broad-spectrum antioxidant. The receptor-dependent functions of melatonin were subsequently acquired during evolution. In the current review, we focus on melatonin metabolism which includes the synthetic rate-limiting enzymes, synthetic sites, potential regulatory mechanisms, bioavailability in humans, mechanisms of breakdown and functions of its metabolites. Recent evidence indicates that the original melatonin metabolite may be N 1 -acetyl-N 2 -formyl-5-methoxykynuramine (AFMK) rather than its commonly measured urinary excretory product 6-hydroxymelatonin sulfate. Numerous pathways for AFMK formation have been identified both in vitro and in vivo. These include enzymatic and pseudo-enzymatic pathways, interactions with reactive oxygen species (ROS)/reactive nitrogen species (RNS) and with ultraviolet irradiation. AFMK is present in mammals including humans, and is the only detectable melatonin metabolite in unicellular organisms and metazoans. 6-Hydroxymelatonin sulfate has not been observed in these low evolutionary-ranked organisms. This implies that AFMK evolved earlier in evolution than 6-hydroxymelatonin sulfate as a melatonin metabolite. Via the AFMK pathway, a single melatonin molecule is reported to scavenge up to 10 ROS/RNS. That the free radical scavenging capacity of melatonin extends to its secondary, tertiary and quaternary metabolites is now documented. It appears that melatonin's interaction with ROS/RNS is a prolonged process that involves many of its derivatives. The process by which melatonin and its metabolites successively scavenge ROS/RNS is referred as the free radical scavenging cascade. This cascade reaction is a novel property of melatonin and explains how it differs from other conventional antioxidants. This cascade reaction makes melatonin highly effective, even at low concentrations, in protecting organisms from oxidative stress. In accordance with its protective function, substantial amounts of melatonin are found in tissues and organs which are frequently exposed to the hostile environmental insults such as the gut and skin or organs which have high oxygen consumption such as the brain. In addition, melatonin production may be upregulated by low intensity stressors such as dietary restriction in rats and exercise in humans. Intensive oxidative stress results in a rapid drop of circulating melatonin levels. This melatonin decline is not related to its reduced synthesis but to its rapid consumption, i.e. circulating melatonin is rapidly metabolized by interaction with ROS/RNS induced by stress. Rapid melatonin consumption during elevated stress may serve as a protective mechanism of organisms in which melatonin is used as a first-line defensive molecule against oxidative damage. The oxidative status of organisms modifies melatonin metabolism. It has been reported that the higher the oxidative state, the more AFMK is produced. The ratio of AFMK and another melatonin metabolite, cyclic 3-hydroxymelatonin, may serve as an indicator of the level of oxidative stress in organisms.

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1600-079X.2006.00407.x

One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species?

Many solid-state kinetic models have been developed in the past century. Some models were based on mechanistic grounds while others lacked theoretical justification and some were theoretically incorrect. Models currently used in solid-state kinetic studies are classified according to their mechanistic basis as nucleation, geometrical contraction, diffusion, and reaction order. This work summarizes commonly employed models and presents their mathematical development.

Solid-State Kinetic Models: Basics and Mathematical Fundamentals

Advanced oxidation process-mediated removal of pharmaceuticals from water: A review.

Heterogeneous photocatalysis using the semiconductor titanium dioxide (TiO2) has proven to be a promising treatment technology for water purification. The effectiveness of this oxidation technology for the destruction of pharmaceuticals has also been demonstrated in numerous studies. This review highlights recent research on TiO2 photocatalytic treatment applied to the removal of selected pharmaceuticals. The discussions are tailored based on the therapeutic drug classes as the kinetics and mechanistic aspects are compound dependent. These classes of pharmaceuticals were chosen because of their environmental prevalence and potential adverse effects. Optimal operational conditions and degradation pathways vary with different pharmaceutical compounds. The main conclusion is that the use of TiO2 photocatalysis can be considered a state-of-the-art pharmaceutical wastewater treatment methodology. Further studies are, however, required to optimize the operating conditions for maximum degradation of multiple pharmaceuticals in wastewater under realistic conditions and on an industrial scale.

/pdf/titanium-dioxide-photocatalysis-for-pharmaceutical-35woo1gtou.pdf

Titanium dioxide photocatalysis for pharmaceutical wastewater treatment

Sunscreens were originally designed to include mainly UVB-filters. Because of the deeper penetration of UVA light, causing photoaging and DNA damage, there has been a shift towards broad spectrum sunscreens. These broad spectrum sunscreens now include both UVA- and UVB-filters and other ingredients which possess antioxidant activity. Although sunscreens are regulated in most countries, photostability testing is not mandatory. Because of the ability of sunscreen ingredients to absorb UV-light and the complexity of most of these formulations, which may include more than one UV-filter, antioxidants and other formulation excipients, it is important that their photostability in combination is determined.

Photostability of sunscreens

Integrated photocatalytic adsorbents (IPA) prepared from TiO2 and natural zeolite were applied to amoxicillin (AMX) degradation. The acid-alkali pre-treated zeolite annealed at 300°C under nitrogen resulted in the best degradation of AMX. The superior performance of this IPA material was explained using scanning electron microscopy (SEM), energy-dispersive spectroscopy (EDS) and X-ray diffraction (XRD). SEM analysis showed an uneven surface as a result of TiO2 cluster deposition, which provides more active sites for adsorption and degradation. XRD results revealed that peaks from more photoactive anatase were more prominent in this IPA material. EDS analyses also confirmed the presence of high amounts of TiO2. Despite their large TiO2 loadings, comparison experiments with untreated zeolite suggested that the pores are still available for adsorption. The overall performance of the IPA material for the degradation of AMX was thus attributed to the adsorption capability of the zeolite carrier, the photocatalytic activity of TiO2 coating and acid-catalyzed hydrolysis ('capture & destroy'). Degradation products resulting from TiO2/zeolite IPA-induced hydrolysis were identified by liquid chromatography-mass spectrometry (LC-MS) prior to photocatalytic treatment. AMX and its thermal degradants were almost completely removed after 240min of irradiation. The efficiency of the developed TiO2/zeolite material provides a potentially economical way of degrading pharmaceutical compounds and recovering photocatalysts simultaneously.

Beverley Glass

Papers

Advanced oxidation process-mediated removal of pharmaceuticals from water: A review.

Titanium dioxide photocatalysis for pharmaceutical wastewater treatment

Photostability of sunscreens

Titanium dioxide/zeolite integrated photocatalytic adsorbents for the degradation of amoxicillin

Molecular aspects of phytoestrogen selective binding at estrogen receptors